Literature DB >> 23494229

Effects of an epilepsy-causing mutation in the SCN1A sodium channel gene on cocaine-induced seizure susceptibility in mice.

Ryan H Purcell1, Ligia A Papale, Christopher D Makinson, Nikki T Sawyer, Jason P Schroeder, Andrew Escayg, David Weinshenker.   

Abstract

RATIONALE: High doses of cocaine can elicit seizures in humans and in laboratory animals. Several mechanisms have been proposed for the induction of seizures by cocaine, including enhanced monoaminergic signaling, blockade of ion channels, and alterations in GABA and glutamate transmission. Mutations in the SCN1A gene, which encodes the central nervous system (CNS) voltage-gated sodium channel (VGSC) Nav1.1, are responsible for several human epilepsy disorders including Dravet syndrome and genetic (generalized) epilepsy with febrile seizures plus (GEFS+). Mice heterozygous for the R1648H GEFS+ mutation (RH mice) exhibit reduced interneuron excitability, spontaneous seizures, and lower thresholds to flurothyl- and hyperthermia-induced seizures. However, it is unknown whether impaired CNS VGSC function or a genetic predisposition to epilepsy increases susceptibility to cocaine-induced seizures.
OBJECTIVES: Our primary goal was to determine whether Scn1a dysfunction caused by the RH mutation alters sensitivity to cocaine-induced behavioral and electrographic (EEG) seizures. We also tested novelty- and cocaine-induced locomotor activity and assessed the expression of Nav1.1 in midbrain dopaminergic neurons.
RESULTS: We found that RH mice had a profound increase in cocaine-induced behavioral seizure susceptibility compared to wild-type (WT) controls, which was confirmed with cortical EEG recordings. By contrast, although the RH mice were hyperactive in novel environments, cocaine-induced locomotor activity was comparable between the mutants and WT littermates. Finally, immunofluorescence experiments revealed a lack of Nav1.1 immunoreactivity in dopaminergic neurons.
CONCLUSION: These data indicate that a disease-causing CNS VGSC mutation confers susceptibility to the proconvulsant, but not motoric, effects of cocaine.

Entities:  

Mesh:

Substances:

Year:  2013        PMID: 23494229      PMCID: PMC3695079          DOI: 10.1007/s00213-013-3034-8

Source DB:  PubMed          Journal:  Psychopharmacology (Berl)        ISSN: 0033-3158            Impact factor:   4.530


  37 in total

1.  Mutations of SCN1A, encoding a neuronal sodium channel, in two families with GEFS+2.

Authors:  A Escayg; B T MacDonald; M H Meisler; S Baulac; G Huberfeld; I An-Gourfinkel; A Brice; E LeGuern; B Moulard; D Chaigne; C Buresi; A Malafosse
Journal:  Nat Genet       Date:  2000-04       Impact factor: 38.330

2.  Progressive behavioral changes during chronic lidocaine administration: relationship to kindling.

Authors:  R M Post; R T Kopanda; A Lee
Journal:  Life Sci       Date:  1975-09-15       Impact factor: 5.037

Review 3.  Neurochemical and pharmacological aspects of cocaine-induced seizures.

Authors:  W Lasoń
Journal:  Pol J Pharmacol       Date:  2001 Jan-Feb

Review 4.  The dopamine-containing neuron: maestro or simple musician in the orchestra of addiction?

Authors:  Antonello Bonci; Giorgio Bernardi; Pernilla Grillner; Nicola B Mercuri
Journal:  Trends Pharmacol Sci       Date:  2003-04       Impact factor: 14.819

5.  Effects of lidocaine on the central nervous system.

Authors:  I H Wagman; R H De Jong; D A Prince
Journal:  Anesthesiology       Date:  1967 Jan-Feb       Impact factor: 7.892

Review 6.  Sodium channel SCN1A and epilepsy: mutations and mechanisms.

Authors:  Andrew Escayg; Alan L Goldin
Journal:  Epilepsia       Date:  2010-09       Impact factor: 5.864

Review 7.  The contribution of comparative studies in inbred strains of mice to the understanding of the hyperactive phenotype.

Authors:  S Cabib; S Puglisi-Allegra; R Ventura
Journal:  Behav Brain Res       Date:  2002-03-10       Impact factor: 3.332

8.  Acute cocaine-induced seizures: differential sensitivity of six inbred mouse strains.

Authors:  G T Golden; T N Ferraro; G G Smith; R L Snyder; N L Jones; W H Berrettini
Journal:  Neuropsychopharmacology       Date:  2001-03       Impact factor: 7.853

9.  Cocaine binds to a common site on open and inactivated human heart (Na(v)1.5) sodium channels.

Authors:  M E O'Leary; M Chahine
Journal:  J Physiol       Date:  2002-06-15       Impact factor: 5.182

10.  Autistic-like behaviour in Scn1a+/- mice and rescue by enhanced GABA-mediated neurotransmission.

Authors:  Sung Han; Chao Tai; Ruth E Westenbroek; Frank H Yu; Christine S Cheah; Gregory B Potter; John L Rubenstein; Todd Scheuer; Horacio O de la Iglesia; William A Catterall
Journal:  Nature       Date:  2012-08-22       Impact factor: 49.962

View more
  5 in total

1.  Early-life febrile seizures worsen adult phenotypes in Scn1a mutants.

Authors:  Stacey B B Dutton; Karoni Dutt; Ligia A Papale; Sandra Helmers; Alan L Goldin; Andrew Escayg
Journal:  Exp Neurol       Date:  2017-04-01       Impact factor: 5.330

2.  Nanoparticle encapsulated oxytocin increases resistance to induced seizures and restores social behavior in Scn1a-derived epilepsy.

Authors:  Jennifer C Wong; Lindsey Shapiro; Jacquelyn T Thelin; Elizabeth C Heaton; Rokon U Zaman; Martin J D'Souza; Kevin S Murnane; Andrew Escayg
Journal:  Neurobiol Dis       Date:  2020-10-25       Impact factor: 5.996

3.  Huperzine A Provides Robust and Sustained Protection against Induced Seizures in Scn1a Mutant Mice.

Authors:  Jennifer C Wong; Stacey B B Dutton; Stephen D Collins; Steven Schachter; Andrew Escayg
Journal:  Front Pharmacol       Date:  2016-10-17       Impact factor: 5.810

4.  What is orgasm? A model of sexual trance and climax via rhythmic entrainment.

Authors:  Adam Safron
Journal:  Socioaffect Neurosci Psychol       Date:  2016-10-25

5.  Identifying and Analyzing Novel Epilepsy-Related Genes Using Random Walk with Restart Algorithm.

Authors:  Wei Guo; Dong-Mei Shang; Jing-Hui Cao; Kaiyan Feng; Yi-Chun He; Yang Jiang; ShaoPeng Wang; Yu-Fei Gao
Journal:  Biomed Res Int       Date:  2017-02-01       Impact factor: 3.411

  5 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.